150 related articles for article (PubMed ID: 3316311)
1. A comparative trial of moxalactam plus ticarcillin and clavulanic acid or piperacillin as empiric antibiotic therapy for febrile cancer patients.
D'Olimpio JT; Miller M; Sheridan CA; Carlisle P; Wollner DI; McKitrick JC; Wiernik PH
J Clin Pharmacol; 1987 Sep; 27(9):673-7. PubMed ID: 3316311
[TBL] [Abstract][Full Text] [Related]
2. Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections.
File TM; Tan JS; Salstrom SJ; Johnson LA; Douglas GF
Antimicrob Agents Chemother; 1984 Sep; 26(3):310-3. PubMed ID: 6508263
[TBL] [Abstract][Full Text] [Related]
3. A controlled study of ticarcillin plus clavulanic acid versus piperacillin as empiric therapy for fever in the immunocompromised host.
Williams ME; Harman C; Scheld M; Hess CE; Donowitz GR
Am J Med; 1985 Nov; 79(5B):67-72. PubMed ID: 3907343
[TBL] [Abstract][Full Text] [Related]
4. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
5. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Cox CE
J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
Mackie MJ; Reilly JT; Purohit S; Bartzokas CA
J Antimicrob Chemother; 1986 May; 17 Suppl C():219-24. PubMed ID: 3522529
[TBL] [Abstract][Full Text] [Related]
7. Timentin versus piperacillin in the therapy of serious urinary tract infections.
File TM; Tan JS; Salstrom SJ; Johnson L
Am J Med; 1985 Nov; 79(5B):91-5. PubMed ID: 4073102
[TBL] [Abstract][Full Text] [Related]
8. Ticarcillin plus clavulanic acid (Timentin) compared with standard antibiotic regimes in the treatment of early and late neonatal infections.
Miall-Allen VM; Whitelaw AG; Darrell JH
Br J Clin Pract; 1988 Jul; 42(7):273-9. PubMed ID: 3075503
[No Abstract] [Full Text] [Related]
9. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
[TBL] [Abstract][Full Text] [Related]
10. Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections.
Siebert WT; Kopp PE
Am J Med; 1985 Nov; 79(5B):141-5. PubMed ID: 4073082
[TBL] [Abstract][Full Text] [Related]
11. Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
Winston DJ; Barnes RC; Ho WG; Young LS; Champlin RE; Gale RP
Am J Med; 1984 Sep; 77(3):442-50. PubMed ID: 6475984
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Wade JC; Schimpff SC; Newman KA; Fortner CL; Standiford HC; Wiernik PH
Am J Med; 1981 Dec; 71(6):983-90. PubMed ID: 6459027
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of ticarcillin plus clavulanate potassium versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Cox CE
Am J Med; 1985 Nov; 79(5B):88-90. PubMed ID: 4073101
[TBL] [Abstract][Full Text] [Related]
14. Ticarcillin plus clavulanic acid versus moxalactam in the treatment of skin and soft tissue infections.
Rao B; See RC; Chuah SK; Bansal MB; Lou MA; Thadepalli H
Am J Med; 1985 Nov; 79(5B):126-9. PubMed ID: 4073078
[TBL] [Abstract][Full Text] [Related]
15. Timentin versus moxalactam in the treatment of skin and soft tissue infections.
Tan JS; File TM; Salstrom SJ
Am J Med; 1985 Nov; 79(5B):130-3. PubMed ID: 4073079
[No Abstract] [Full Text] [Related]
16. Ticarcillin plus clavulanic acid (Timentin)--further UK trial results.
Tehan S; Horobin J; Gordonsmith R; McLatchie GR
Br J Clin Pract; 1988 Jan; 42(1):8-16. PubMed ID: 3058192
[No Abstract] [Full Text] [Related]
17. Timentin (ticarcillin and clavulanic acid) in combination with aminoglycosides in the treatment of febrile episodes in neutropenic children.
Schaison G; Reinert P; Leverger G; Leauté JB
J Antimicrob Chemother; 1986 May; 17 Suppl C():177-81. PubMed ID: 3722043
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid.
Roselle GA; Bode R; Hamilton B; Bibler M; Sullivan R; Douce R; Staneck JL; Bullock WE
Antimicrob Agents Chemother; 1985 Mar; 27(3):291-6. PubMed ID: 3888101
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.
Tan JS; Wishnow RM; Talan DA; Duncanson FP; Norden CW
Antimicrob Agents Chemother; 1993 Aug; 37(8):1580-6. PubMed ID: 8215266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
